This spin-out company from the University of Nottingham has developed a unique reactor technology to allow unprecedented product control and flexibility in inorganic nanoparticle dispersion manufacture.
The company is developing intelligent medicine products internally and in partnership with device, pharmaceutical and biotechnology companies. These products address therapeutic areas where disease management complexity, patient monitoring requirements, therapeutic efficacy, and poor patient adherence create large clinical and commercial opportunities.
Proxeon develops state-of-the-art solutions to solve many of the scientific and technical challenges that are faced by those working in the field of proteomics. The company's core competencies are in the areas of mass spectrometry, protein analysis, hardware and software design for proteome analysis.
Physical Sciences Inc. focuses on providing contract research and development services in a variety of technical areas to both government and commercial customers. New materials developments include nanoparticle-derived constructs.
PureLux is a spin-out from the Center for Nanotechnology and Molecular Materials at Wake Forest University focused on commercializing next generation light sources that are 10 times more efficient than incandescents and 3 times more efficient than fluorescents.
This electronic design automation (EDA) company is developing new integrated circuit (IC) and system on chip (SoC) routing software for complex nanometer IC designs. Their solution is an architecture optimized for the challenges of sub-100 nm manufacturing process technology.